Hogge Gary S.
- SEC CIK
- 0001771711
No open-market purchases or sales filed in the past year.
Current role at each company
- LCTX Lineage Cell Therapeutics, Inc.SVP,Clinical & Medical Affairsas of Mar 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hogge Gary S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2021 (view filing) | Dec 28-29 | 2 days | Hogge Gary S.SVP,Clinical & Medical Affairs | SSaleCommon Shares, no par value | −539.3K | $2.45 | −$1.32M | −100.0%0 after | 3 lots |